The pandemic caused by the novel coronavirus has presented significant
challenges to global health systems and economies. The urgent search
for effective therapeutic interventions to control the disease underscores the
importance of understanding its underlying pathophysiology. The bacillus Calmette–Guérin (BCG)
vaccine is known to activate and modulate innate immune responses,
and its potential protective effect against the novel coronavirus warrants
systematic investigation.